Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06483360

Methane and Hydrogen Breath Test for the Diagnosis of Small Intestinal Bacterial Overgrowth

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
750 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To investigate whether the positive rates of methane and hydrogen breath test were different between the experimental group and the control group.

Detailed description

Small intestinal bacterial overgrowth (SIBO) refers to a syndrome of gastrointestinal symptoms caused by changes in the number and/or type of bacteria in the small intestine, and is considered to be secondary to changes in intestinal anatomy, slowing of intestinal motility, or abnormalities in gastrointestinal function. Clinical symptoms of SIBO are atypical, and are mainly characterized by bloating, belching, abdominal pain, diarrhea, constipation, and changes in stool shape, color, odor, and other characteristics. Since the clinical symptoms of SIBO are not specific and the clinical diagnosis criteria are not standardized, its treatment has not been given enough attention.

Conditions

Timeline

Start date
2024-09-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2024-07-03
Last updated
2024-08-27

Source: ClinicalTrials.gov record NCT06483360. Inclusion in this directory is not an endorsement.

Methane and Hydrogen Breath Test for the Diagnosis of Small Intestinal Bacterial Overgrowth (NCT06483360) · Clinical Trials Directory